Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin as Adjunct to Methotrexate in Rheumatoid Arthritis
NCT04068246Phase 2Completed
- Sponsor
- Sadat City University
- Start
- Aug 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of liquid metformin (Aspargo Labs) in rheumatoid arthritis (RA), sponsored by Sadat City University. Primary endpoints: ACR 20% improvement criteria at 12 weeks, ACR 50% improvement criteria at 12 weeks and 2 more. Started Aug 2019; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT04068246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04068246.